LI
COLL icon

Leap Investments’s Collegium Pharmaceutical COLL Stock Holding History

Leap Investments’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$205K Buy
+11,700
New +$229K 0.14% 290

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Leap Investments's COLL Position: Q2 2020 in Review

Leap Investments opened a new position in Collegium Pharmaceutical (COLL) in Q2 2020: 11,700 shares worth $205K. The stake represents 0.14% of the portfolio and ranks #290 among its holdings.

150 funds tracked by Wall St. Rank hold COLL as of Q2 2020.

  • Leap Investments held 11,700 shares of Collegium Pharmaceutical worth $205K as of Q2 2020.
  • Collegium Pharmaceutical was a new Leap Investments position in Q2 2020.
  • Collegium Pharmaceutical made up 0.14% of Leap Investments's portfolio in Q2 2020, its #290 holding.
  • 150 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.